This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Glucagon prescriptions for severe hypoglycemia rose in Medicaid beneficiaries with the introduction of newer products but likely met only a fraction of the high-risk population’s needs.
Medscape Medical News